Part II from Part I

This is the second part to the first part that you helped me with. I am attaching it to this email. This was due yesterday and I forgot about it so I’m kind of pressed for time.

Part II: Evidence Retrieval Due: November 13, 2023Retrieve evidence that is relevant to the topic via a literature review of pertinent clinical researchstudies, systematic reviews, meta-analyses, and non-research practice and/or theory literature• It is important to find the strongest evidence available in the quest for knowledge aboutthe selected topic – each reference must include the level of evidence. Use the evidencepyramid in LoBiondo-Wood & Haber (10 th ed.) on p. 15 to identify the strength of yourevidence.• A minimum of 10 references should be included on your reference list.• All references are to be published within the last 5 years with few exceptions. If thereference is considered a “gold standard” for being the first to identify aphenomenon, theory, etc., then it is fine to include it as a reference (even if it is morethan 5 years old).• An APA formatted list of references will be submitted. Following the reference list,on an additional sheet of paper, please include the following information: 1)Author(s) last name(s), 2) Title of article, 3) Level of evidence according to theevidence pyramid discussed above. This 2-part assignment will be submittedtogether with one APA formatted title page

Project Part I
Shana Spratt
College of Nursing, Elms
November 6, 2023
Introduction
• Opioid overdose is a common problem within the healthcare setting.
• This challenge affects patients and may lead to addiction and overdependence (Scholl et al.,
2019).
• Practitioners at the rehabilitation center like inpatient detox are responsible for health promotion.
• Some ways to achieve the expected goals is by:
• Implementing educational interventions.
• Adopting preventive measures.
• This project addresses the need and impacts of adopting Naloxone Distribution overdose
education program in opioid overdose detection and reversal.
The topic
• This project has selected the topic concerning the adoption of the Naloxone
Distribution overdose education program guidelines.
• The rationale for selecting this project is:
• The need to prevent opioid overdose in the tertiary setting.
• Develop a mechanism for understanding and detecting opioid overdose.
• The program will focus on reversing the impacts of the challenge by
promoting wellness and general patient wellbeing (Scholl et al., 2019).
The problem statement
• The topic in the context reflects on the prevalence of opioid and drug
overdose incidents.
• In the United States, drug overdose mortality has increased:
• 3,442 to 17,029 between 1999 and 2017 (Scholl et al., 2019).
• Opioid overdose mortality:
• Increased to 75.4% in 2021 (CDC, 2023).
• Preventing drug overdose is critical for health promotion.
Problem-focused and knowledge-focused
triggers
• Opioid overdose is a common challenge that can be understood from multiple
dimensions.
• Problem focused triggers
• Knowledge focused triggers
• Many patients are prescribed opioids due to underlying conditions.
• Knowledge gaps may accelerate the condition.
• The proposed initiative should priorities knowledge delivery and practice expertise
to mitigate the associated challenges (Scholl et al., 2019).
Hypothetical team
•
This project will benefit from a multidimensional and disciplinary team comprising:
•
Nurse practitioners
•
•
Certified nurse assistants
•
•
2 members
Nurse educators
•
•
3 members
Nurse anesthetists
•
•
2 members
5 members
•
To educate other practitioners, patients and family members.
•
To assist in developing community- based programs.
Clinical nurse specialists
•
2 members.
•
Family members
•
Patients
•
Community nurses
•
5 members:
•
To coordinate the community -based interventions in health promotion (Razaghizad et al., 2021).
Key stakeholders
•
This project will be influenced by the respective stakeholders.
•
The stakeholders likely to support the project are:
•
Community based nurses
•
Family members
•
Patients
•
The initiative is concerned about health promotion.
•
It will reduce risks of overdose.
•
It will help patients suffering from an overdose.
•
Nurse educators
•
The potential resistance may come from:
•
Nurse assistants
•
Nurse anesthetists
•
Nurse practitioners
•
The rationale for this resistance is disruption of their normal working patterns (Razaghizad et al., 2021).
Impacts of stakeholders on project
implementation
• The supporting stakeholders will include:
• Community health nurses
• Family members
• Patients
• Nurse educators
• These stakeholders will support the initiative because of the capacity:
• To identify and detect overdose incidents.
• To establish a preventive measure against overdose.
• To facilitate reversal (Wilson et al., 2020).
Evidence based practice question
•
•
•
•
•
•
•
•
The problem above can be formulated using an evidence-based framework.
This statement can be presented as follows:
P: Practitioners, patients and family members (Razaghizad et al., 2021).
I: Developing guidelines for a Naloxone Distribution overdose education program
C: No guidelines
O: Reducing overdose rates
PICO Question:
Among practitioners, family members and patients, what is the effect of developing Naloxone Distribution
education program guidelines in detecting, reversing and preventing opioid overdose compared to no
interventions?
Conclusion
•
•
•
•
This project proposes the development of guidelines for opioid detection, reversal and prevention.
In this intervention, the proposed guidelines will involve:
•
Nurses within the tertiary setting.
•
Family members.
•
Patients.
It is expected that the initiative:
•
Will help practitioners to identify at risk patients.
•
Understand signs and symptoms.
•
Promote early detection.
•
Reverse existing overdose incidents.
Empower patients and family members with:
•
Knowledge to identify knowledge gaps and triggers.
References
• CDC. (2023). Drug Overdose Deaths. CDC.
https://www.cdc.gov/drugoverdose/deaths/index.html#:~:text=Opioids%E2%80%94mainly%
20synthetic%20opioids%20(other,of%20all%20drug%20overdose%20deaths).
• Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved
overdose deaths—United States, 2013–2017. Morbidity and mortality weekly report, 67(51-52), 1419.
• Wilson, N., Kariisa, M., Seth, P., Smith IV, H., & Davis, N. L. (2020). Drug and opioid-involved
overdose deaths—United States, 2017–2018. Morbidity and Mortality Weekly Report, 69(11), 290.
• Razaghizad, A., Windle, S. B., Filion, K. B., Gore, G., Kudrina, I., Paraskevopoulos, E., … &
Eisenberg, M. J. (2021). The effect of overdose education and naloxone distribution: an umbrella
review of systematic reviews. American journal of public health, 111(8), e1-e12.